Sarah E J Bowman1, Jennifer Bridwell-Rabb1, Catherine L Drennan1. 1. Department of Chemistry, ‡Department of Biology, and §Howard Hughes Medical Institute, Massachusetts Institute of Technology , 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
Abstract
Metal ions and metallocofactors play important roles in a broad range of biochemical reactions. Accordingly, it has been estimated that as much as 25-50% of the proteome uses transition metal ions to carry out a variety of essential functions. The metal ions incorporated within metalloproteins fulfill functional roles based on chemical properties, the diversity of which arises as transition metals can adopt different redox states and geometries, dictated by the identity of the metal and the protein environment. The coupling of a metal ion with an organic framework in metallocofactors, such as heme and cobalamin, further expands the chemical functionality of metals in biology. The three-dimensional visualization of metal ions and complex metallocofactors within a protein scaffold is often a starting point for enzymology, highlighting the importance of structural characterization of metalloproteins. Metalloprotein crystallography, however, presents a number of implicit challenges including correctly incorporating the relevant metal or metallocofactor, maintaining the proper environment for the protein to be purified and crystallized (including providing anaerobic, cold, or aphotic environments), and being mindful of the possibility of X-ray induced damage to the proteins or incorporated metal ions. Nevertheless, the incorporated metals or metallocofactors also present unique advantages in metalloprotein crystallography. The significant resonance that metals undergo with X-ray photons at wavelengths used for protein crystallography and the rich electronic properties of metals, which provide intense and spectroscopically unique signatures, allow a metalloprotein crystallographer to use anomalous dispersion to determine phases for structure solution and to use simultaneous or parallel spectroscopic techniques on single crystals. These properties, coupled with the improved brightness of beamlines, the ability to tune the wavelength of the X-ray beam, the availability of advanced detectors, and the incorporation of spectroscopic equipment at a number of synchrotron beamlines, have yielded exciting developments in metalloprotein structure determination. Here we will present results on the advantageous uses of metals in metalloprotein crystallography, including using metallocofactors to obtain phasing information, using K-edge X-ray absorption spectroscopy to identify metals coordinated in metalloprotein crystals, and using UV-vis spectroscopy on crystals to probe the enzymatic activity of the crystallized protein.
Metal ions and metallocofactors play important roles in a broad range of biochemical reactions. Accordingly, it has been estimated that as much as 25-50% of the proteome uses transition metal ions to carry out a variety of essential functions. The metal ions incorporated within metalloproteins fulfill functional roles based on chemical properties, the diversity of which arises as transition metals can adopt different redox states and geometries, dictated by the identity of the metal and the protein environment. The coupling of a metal ion with an organic framework in metallocofactors, such as heme and cobalamin, further expands the chemical functionality of metals in biology. The three-dimensional visualization of metal ions and complex metallocofactors within a protein scaffold is often a starting point for enzymology, highlighting the importance of structural characterization of metalloproteins. Metalloprotein crystallography, however, presents a number of implicit challenges including correctly incorporating the relevant metal or metallocofactor, maintaining the proper environment for the protein to be purified and crystallized (including providing anaerobic, cold, or aphotic environments), and being mindful of the possibility of X-ray induced damage to the proteins or incorporated metal ions. Nevertheless, the incorporated metals or metallocofactors also present unique advantages in metalloprotein crystallography. The significant resonance that metals undergo with X-ray photons at wavelengths used for protein crystallography and the rich electronic properties of metals, which provide intense and spectroscopically unique signatures, allow a metalloprotein crystallographer to use anomalous dispersion to determine phases for structure solution and to use simultaneous or parallel spectroscopic techniques on single crystals. These properties, coupled with the improved brightness of beamlines, the ability to tune the wavelength of the X-ray beam, the availability of advanced detectors, and the incorporation of spectroscopic equipment at a number of synchrotron beamlines, have yielded exciting developments in metalloprotein structure determination. Here we will present results on the advantageous uses of metals in metalloprotein crystallography, including using metallocofactors to obtain phasing information, using K-edge X-ray absorption spectroscopy to identify metals coordinated in metalloprotein crystals, and using UV-vis spectroscopy on crystals to probe the enzymatic activity of the crystallized protein.
The chemical versatility of transition
metals leads to their essential
roles in enzymatic systems. It has been estimated that 25–50%
of all proteins found within an organism contain metal ions.[1,2] In a systematic assessment of protein structures deposited in the
PDB at the time of this Account, of the 99 827 structures determined
using X-ray crystallography, 21 989 contain transition metals
or metallocofactors. Therefore, approximately 22% of protein structures
deposited in the PDB contain biologically relevant d-block transition
metals or cofactors such as heme, iron–sulfur (Fe–S)
cluster, and cobalamin (Cbl), which establishes a lower bound to the
number of proteins in the proteome that coordinate metals. Once incorporated
within enzymes, metal ions expand the catalytic repertoire of enzymes.
For example, iron plays roles in electron transfer, radical chemistry,
and activation of oxygen, nickel functions in biological carbon, nitrogen,
and oxygen cycles, copper is important in electron transport and oxidation–reduction
reactions, and zinc plays roles in maintaining protein structure or
acting as a Lewis acid to facilitate chemistry.[3]This diversity of function comes at a price, because
almost all
free transition metal ions are toxic when in excess; organisms must
strictly regulate metal ion uptake, use, and export, and must ensure
that the correct metal is incorporated into the correct protein. Metallochaperones
are often employed during metallocofactor biosynthesis, protecting
organisms from toxic effects of free cofactors or their building blocks.[4] To these ends, elaborate multicomponent Fe–S
cluster assembly systems have evolved for maturation and delivery
of Fe–S cluster cofactors.[5] Likewise,
specialized systems are required for the maturation and assembly of
the catalytic H cluster in Fe–Fe hydrogenase,[6] the biosynthesis and insertion of the P-cluster and iron
molybdenum cofactor (FeMoco) of nitrogenase,[7] and the maturation of the nickel-containing C-cluster of the Rhodospirillum rubrum carbon monoxide dehydrogenase (CODH).[8]Crystal structures determined from data
collected using synchrotron
radiation provide high-resolution snapshots of biomolecules. Improvements
at beamlines, including higher brightness, flux, and availability
of advanced detectors, has led to better quality data and higher-resolution
crystal structures. A notable example of these improvements is the
structure that resolved the identity of the light atom in nitrogenase,
the enzyme that converts atmospheric nitrogen to ammonia. The original
2.2 Å resolution structure of nitrogenase detailed an FeMoco
with a geometrically complex arrangement of six inner iron atoms and
nine surface sulfur atoms.[9] This arrangement
of identical scatterers resulted in additive ripple effects from each
atom, effectively concealing the central light atom and leading to
the initial incorrect interpretation of an empty pocket.[10] In a later 1.16 Å resolution structure,
a light atom at the center of the FeMoco was observed but unable to
be unambiguously assigned.[11] The light
atom X was speculated to be carbon, nitrogen, or oxygen, which led
to a broad range of proposed mechanisms.[11,12] The correct identification of atom X was the focus of much scientific
investigation (and heated debate). The recently solved 1.0 Å
resolution structure allowed for clear identification of X as a carbon
atom.[13]Concomitant with improvements
available from brighter synchrotron
sources are the potentially damaging effects of X-ray radiation. These
deleterious effects are of special concern in biomolecules containing
transition metals because these atoms are often more susceptible to
radiation damage and oxidation state changes. Using multiple methods
to investigate structural questions has the advantage of providing
complementary information and additional insight into function and
mechanism. The power of using different experimental techniques can
be observed by revisiting the nitrogenase mystery. In addition to
higher resolution crystallographic data, assignment of X to carbon
was confirmed using electron spin echo envelope modulation studies.[13] An independent spectroscopic study using X-ray
emission spectroscopy also identified the central X atom as carbon.[14] Using parallel spectroscopic techniques on solution
and crystal samples can determine whether a crystallographically observed
conformation of an enzyme is an active or inactive state.[15] Combining crystallography with in crystallo spectroscopic techniques can yield large amounts of information.
Early examples include identification of X-ray damage to the Mn4Ca complex in photosystem II[16] and
assignment of individual iron oxidation states in the [2Fe–2S]
clusters of ferredoxin crystals using X-ray absorption (XAS).[17] A variety of spectroscopic techniques have since
been incorporated into equipment available at synchrotron beamlines
to both assess potential synchrotron radiation difficulties and gain
insight into the mechanisms of metalloproteins with crystallographically
determined structures (Table ).[18,19] Microspectrophotometry on metalloprotein
crystals can yield information about the metal redox state(s), identify
which metals and cofactors are present, and assess radiation damage
caused by the X-ray beam.[20−22] Techniques that take advantage
of K-edge absorption energies, of particular use in characterizing
spectroscopically silent metals, include energy dispersive emission
line scans (EDX), which can identify what metals are present, and
X-ray absorption near edge structure (XANES) and extended X-ray absorption
fine structure (EXAFS), both of which can identify redox state changes
and provide geometric constraints for structural refinement.[17,18,23] Resonance Raman on single crystals
provides information about redox state changes and metal–ligand
interactions.[24,25] These techniques have been utilized
on single crystals in parallel and simultaneous modes, before, during,
and after X-ray data collection, in a variety of cases in which the
spectroscopy has led to a better understanding of the structural results.
Development of equipment at synchrotron sources that allows for concurrent
spectroscopic data has been exploding, and in this Account, we discuss
examples of the types of information that can be obtained from a range
of available in situ synchrotron techniques for investigating
metalloprotein crystals.
Table 1
Techniques Available
at Macromolecular
Crystallographic Diffraction Data Collection Beamlinesa
country
synchrotron
beamline
technique
Canada
Canadian Light Source
CMCF-BM
EDX, XANES, EXAFS
CMCF-1D
EDX, XANES
China
Beijing Synchrotron Radiation Facility
1W2B
EDX, EXAFS
France
European Synchrotron Radiation Facility
ID29S
UV–vis, fluorescence, Raman (offline)
ID29
Raman
Japan
Spring-8
BL38B1
UV–vis
Switzerland
Swiss Light Source
X10SA
UV–vis, resonance Raman
United Kingdom
Diamond Light Source
MX 102, 103, 104 and 124
UV–vis
United States
Advanced Photon Source
14-BM-C
UV–vis
21-ID-D
EDX
24-ID-E, 24-ID-C
EDX
Stanford Synchrotron Radiation Lightsource
9-2
UV–vis, EDX, Raman
11-1
UV–vis, EDX
9-1, 12-2
EDX
As indicated
on their websites.
Some of the beamlines could have additional unlisted capabilities.
As indicated
on their websites.
Some of the beamlines could have additional unlisted capabilities.
Challenges of Metalloprotein
Crystallography
Protein Preparation
There are additional
challenges
in preparing samples for metalloprotein crystallography, because the
correct metal center must be incorporated into the protein. In some
cases, samples can be purified from the native organism containing
the correct metal ion or metallocofactor, as exemplified by nitrogenase
from Azotobacter vinelandii,(26) corrinoid Fe–S protein (CFeSP) from Moorella thermoacetica,(15) and R. rubrum CODH.[27] Alternatively, BtrN[28] and anSME[29] are examples of enzymes that
have been purified recombinantly in Escherichia coli with intact [4Fe–4S] clusters through coexpression with the
Fe–S cluster assembly operon (isc) from A. vinelandii.[5] Similarly, coexpression
of the hydrogenase maturation genes (hydEF, hydG, and hydA) in E. coli leads to formation of an active Fe–Fe hydrogenase.[6]In other cases, crystallization has been
successful after anaerobic reconstitution of [4Fe–4S] clusters
before crystallization,[30] through copurification
from E. coli with an intact [4Fe–4S] cluster,[31] or using a combination of the isc operon and anaerobic reconstitution.[32] Excitingly, a structure of the Fe–Fe hydrogenase was recently
determined in the presence of a semisynthetic H-cluster.[33] These additional steps to correctly reconstitute
proteins for crystallography should be accompanied by complementary
techniques to ensure correct incorporation.
Metalloprotein Crystallization
Metallocofactors including
Fe–S clusters, FeMoco, and the H-cluster are notoriously susceptible
to oxygen-induced degradation,[34] whereas
the adenosylcobalamin (AdoCbl) cofactor is sensitive to light; both
require special handling (Figure ).
Figure 1
Anaerobic and aphotic crystallization setups. (A) Setup
for metalloprotein
crystallization under anaerobic conditions in an MBraun glovebox.
Screens can be set up on the mosquito robot; crystal trays are stored
and automatically imaged in the Formulatrix RI-182 within a custom
designed chamber (Rebekah Bjork, Drennan Laboratory). (B) Light sensitive
crystals are imaged and looped in a dark room equipped with red light.
Anaerobic and aphotic crystallization setups. (A) Setup
for metalloprotein
crystallization under anaerobic conditions in an MBraun glovebox.
Screens can be set up on the mosquito robot; crystal trays are stored
and automatically imaged in the Formulatrix RI-182 within a custom
designed chamber (Rebekah Bjork, Drennan Laboratory). (B) Light sensitive
crystals are imaged and looped in a dark room equipped with red light.For a protein with an active site
metal center rather than a metallocluster,
there are two methods for incorporating the metal of interest: soaking
and cocrystallization. The structure of NikR, determined after soaking
crystals with 8 mM nickel chloride, revealed 22 low-affinity nickel
sites.[35] Here, cocrystallization was not
an option because NikR precipitated when mixed with high nickel concentrations
prior to crystallization.[35] Likewise, cocrystallization
of the GTPase YjiA with Zn2+ was unsuccessful; therefore
apo-YjiA crystals were grown and then soaked in a solution containing
excess zinc sulfate.[36] For SyrB2, which
requires an oxygen-sensitive Fe2+ center, crystals were
grown aerobically and then transferred into an anaerobic chamber for
soaking.[37]
X-ray Induced Changes to
Metal Centers
Radiation damage
to crystals is caused by X-ray generated free radicals. The diffusion
rate of free radical species is reduced significantly at low temperature,
and therefore X-ray experiments are performed with samples held at
100 K.[38] In the 1990s, it was estimated
that the “lifetime” of a frozen crystal in the X-ray
beam at a synchrotron was about 1 day.[39] Today, with the advent of third-generation synchrotrons, the predicted
lifetime of a crystal at cryogenic temperatures is ∼5 min (the
time it takes to collect one data set).[40,41] During data
collection, at a wavelength of 1 Å, it is estimated that ∼10%
of the X-ray photons exposed to a sample are elastically scattered
and contribute useful information to structure determination.[42] This phenomenon means that the remaining 90%
of photons will deposit their energy into the crystal, possibly causing
global or specific damage.[42] Global damage
is reflected in increased B-factors, higher mosaicity, higher Rsym, and lower resolution, whereas specific
damage results in disulfide bond breaks, cysteine and methionine side
chain oxidation, decarboxylation of acidic residues, or phenylalanine
and tyrosine hydroxylation.[40,42] For metalloproteins,
radiation damage can additionally lead to photoreduction.[20]Redox state changes can impact the interpretation
of metalloprotein crystal structures. For example, XAS experiments
were performed on a series of free and protein-bound Cbl samples.
The spectra of Co(II)–Cbl, methylcobalamin, and AdoCbl were
similar before and after X-ray exposure.[43] The spectra of aquocobalamin and cyanocobalamin, however, were substantially
altered by exposure to irradiating energies.[43] In another example, a series of crystal structures were solved for
variants of cytochrome c (cyt c),
a heme-containing protein from Nitrosomonas europea that functions in electron transfer reactions.[44] Previous EPR data of the variants showed differences in
the heme electronic state.[45] Here, crystal
structures were determined for the variants to correlate structural
changes to electronic changes. The crystallographic analysis revealed
some evidence of structural changes of the heme active site. Concomitant
UV–vis data collected on protein crystals are consistent with
Fe3+-cyt c prior to X-ray exposure (the
EPR active state) and Fe2+-cyt c after
data collection (Figure ). These results may indicate that reduction of Fe3+ induces
changes in both the heme electronic structure and observed Fe–ligand
distance, factors that need to be considered when interpreting crystallographic
results. An exquisite set of experiments was performed on cytochrome c peroxidase (CCP), another heme protein, to investigate
the molecular nature of Compound I.[46] In
CCP crystal structures, the observed Fe–O bond length was ∼1.9
Å, significantly different from the bond lengths of 1.7 Å
observed using spectroscopic methods. The shorter distance is consistent
with an Fe(IV)=O species, whereas the longer distance is consistent
with a protonated Fe(IV)–OH species. To examine whether the
X-ray beam was correlated with lengthening the Fe–O bond, single-crystal
spectroscopy and X-ray diffraction data were collected on ∼100
crystals, with a data collection strategy that allowed only brief
exposure of each crystal to the X-ray beam.[46] These results showed the Fe–ligand bond length increases
as a function of X-ray exposure, indicating previous X-ray structures
had a mixed population of iron species, explaining the longer observed
Fe–O bond lengths, and suggesting the longer bond length is
an artifact caused by X-ray exposure.[46]
Figure 2
The
X-ray beam causes reduction of the bound metallocofactor highlighting
the importance of parallel techniques in metalloprotein crystallography.
Characteristic bands indicate a low-spin Fe3+ state prior
to X-ray exposure; appearance of the 613 nm band postexposure suggests
some high-spin Fe2+, consistent with ligand loss.[44] In the NeN64D variant, low-spin
Fe3+ is reduced to low-spin Fe2+, evidenced
by Q-bands at 520 and 550 nm.[44] Reproduced
with permission from ref (44). Copyright 2013 Wiley-VCH Verlaf GmbH&Co, KGaA, Weinheim.
The
X-ray beam causes reduction of the bound metallocofactor highlighting
the importance of parallel techniques in metalloprotein crystallography.
Characteristic bands indicate a low-spin Fe3+ state prior
to X-ray exposure; appearance of the 613 nm band postexposure suggests
some high-spin Fe2+, consistent with ligand loss.[44] In the NeN64D variant, low-spin
Fe3+ is reduced to low-spin Fe2+, evidenced
by Q-bands at 520 and 550 nm.[44] Reproduced
with permission from ref (44). Copyright 2013 Wiley-VCH Verlaf GmbH&Co, KGaA, Weinheim.
Crystallographic Refinement
of Metal Centers
When the
structure of a metal center is not known prior to the metalloprotein
structure determination, care must be taken in how the metal site
is refined.[23] Crystallographic parameters,
such as bond lengths and angles, are well-established for proteins,
but not for metal sites, and there is not a universally accepted strategy
for refinement of metal centers.[1] Some
crystallographers do not use distance or angle restraints when refining
a metal site, afraid to bias the resulting structure. With high resolution
data, this approach can work, but with modest resolution, this method
can be dangerous. For example, refinement protocols are designed to
alleviate clashes caused by atoms that are closer together than their
van der Waals radii. Since most metal–ligand distances are
shorter than this (2.2 Å is a typical Fe–cysteine distance),
refinement can push apart atoms that should be close, biasing the
resulting structure. For this reason, other crystallographers restrain
metal–protein distances, using values from spectroscopy, from
small molecule structures, or from other related metalloprotein structures.
A general rule of thumb is that if you are not losing sleep over the
refinement of the metal center, you are not being careful enough.
Advantages of Metalloproteins
The wealth of information
and surprises revealed by metalloprotein
crystallography outweigh its challenges. For example, the crystal
structure of the non-heme iron halogenase SyrB2, which catalyzes the
Fe2+/α-ketoglutarate-dependent halogenation of threonine
to 4-chloro-threonine using oxygen and chloride as substrates, revealed
an unprecedented iron coordination to a chloride ion (Figure ).[37] Importantly, this structure provided insight into how SyrB2 uses
an Fe2+/α-ketoglutarate-dependent enzyme scaffold
that traditionally catalyzes hydroxylation reactions to instead catalyze
halogenation.[37] In other cases, metalloprotein
crystal structures have served as inspiration for synthetic chemists
because they permit the molecular visualization of complicated metallocofactors.
Since many metals have rich electronic properties that provide intense,
spectroscopically unique signatures, spectroscopic characterization
of metalloprotein crystals can provide detailed information about
the metal site. Proteins that contain metals with strong absorption
signals are ideally suited for parallel experiments; optical properties
of a small subset of metalloproteins are listed in Table .
Figure 3
Crystal structure of
SyrB2 provides insight into the halogenation
mechanism. (A.) Active site of SyrB2, detailing an octahedral iron
(brown sphere) geometry with two histidine ligands, α-ketoglutarate,
water (blue sphere), and a chloride ion (green sphere).[37] 2Fo – Fc electron density maps are shown in blue mesh
and contoured at 1.0σ. (B.) A dispersive difference Fourier
map from a SyrB2 crystal that contained bromide (purple sphere).[37] This map, calculated by subtracting data collected
at the iron edge (1.7340 Å) from data collected at the bromide
edge (0.9197 Å), shows a positive density peak for bromine (purple
mesh contoured at 4.0σ), and a negative density peak for iron
(brown mesh contoured at −4.0σ) due to the differential
scattering of these two ions at these wavelengths. Panel B was reprinted
from ref (37).
Table 2
Optical Properties
of Some Protein
Bound Metal Centers
metal
example protein
redox state
optical
properties
“main” peaks
(nm)
ε (M–1 cm–1)
cobalt
methionine
synthase[47]
Co(III)
strong
352
20200
Co(II)
strong
475
9470
Co(I)
strong
525
10000
iron
(heme)
cyt c(48)
Fe(III)
strong
410
100000
Fe(II)
strong
413, 521, 550
125000, 1550,
2900
iron (Fe–S)
rubredoxin[49]
Fe(III)
strong
350, 380, 490
7000, 7700, 6600
Fe(II)
silent
copper
nitrite reductase[50]
type I Cu(II)
strong
600
2880
nickel
nickel superoxide dismutase[51]
Ni(III)
strong
378
6000
Ni(II)
weak
450
<500
Crystal structure of
SyrB2 provides insight into the halogenation
mechanism. (A.) Active site of SyrB2, detailing an octahedral iron
(brown sphere) geometry with two histidine ligands, α-ketoglutarate,
water (blue sphere), and a chloride ion (green sphere).[37] 2Fo – Fc electron density maps are shown in blue mesh
and contoured at 1.0σ. (B.) A dispersive difference Fourier
map from a SyrB2 crystal that contained bromide (purple sphere).[37] This map, calculated by subtracting data collected
at the iron edge (1.7340 Å) from data collected at the bromide
edge (0.9197 Å), shows a positive density peak for bromine (purple
mesh contoured at 4.0σ), and a negative density peak for iron
(brown mesh contoured at −4.0σ) due to the differential
scattering of these two ions at these wavelengths. Panel B was reprinted
from ref (37).
Phase Determination
Metal centers within a protein
provide a native way to determine phase information with single-wavelength
anomalous dispersion (SAD) or multiwavelength anomalous dispersion
(MAD) experiments, techniques that have become mainstream with increased
availability of wavelength-tunable synchrotron facilities. For both S-adenosylmethionine radical enzymes, anaerobic sulfatase
maturating enzyme (anSME) from Clostridium perfringens and 7-carboxy-7-deazaguanine synthase (QueE) from Burkholderia
multivorans, phases were determined by SAD methods with data
collected from a rotating copper anode home source at the Cu Kα
edge (1.54178 Å).[29,32] The enzyme anSME has three [4Fe–4S]
clusters per monomer, and QueE has one [4Fe–4S] cluster per
monomer (Figure A,B).[29,32] Both structures show the utility of the incorporated [4Fe–4S]
clusters; because there is significant iron anomalous signal at the
Cu Kα edge, the presence of the metallocofactor allowed phases
to be obtained and structures to be solved from a home source (Figure C).
Figure 4
Data collected at the
Cu Kα edge can be used to determine
phases for Fe–S cluster containing protein structures. The
crystal structures of (A) anSME[29] and (B)
QueE[32] were solved using the anomalous
signal of protein-bound [4Fe–4S] clusters and data collected
at the Cu Kα edge. (C) Calculated anomalous scattering at the
Fe and Cu K edge. Plot generated with edgeplots web tool from http://skuld.bmsc.washington.edu/scatter/.
Data collected at the
Cu Kα edge can be used to determine
phases for Fe–S cluster containing protein structures. The
crystal structures of (A) anSME[29] and (B)
QueE[32] were solved using the anomalous
signal of protein-bound [4Fe–4S] clusters and data collected
at the Cu Kα edge. (C) Calculated anomalous scattering at the
Fe and Cu K edge. Plot generated with edgeplots web tool from http://skuld.bmsc.washington.edu/scatter/.Another option to determine or improve phases for metalloprotein
structures is to use the wavelength dependence of X-ray diffraction
(known as dispersive differences) for the given metal and collect
data using a tunable synchrotron beamline. The structures of biotin
synthase and pyruvate formate-lyase activating enzyme, both of which
contain Fe–S clusters, were determined to 2.25 Å and 3.4
Å resolution using iron MAD techniques.[30,31] The phasing power of incorporated metalloclusters not only pertains
to iron; a recent example of phasing from the incorporated metallocofactor
is the crystal structure of CarH, a photoreceptor that uses one molecule
of AdoCbl per monomer as a light-dependent switch to mediate transcription
regulation.[52] The structure of the light-sensing
domains of CarH was solved using data collected at the cobalt peak
wavelength (1.6039 Å), and a SAD experiment was used to locate
the cobalt of AdoCbl (Figure ).[52] Of course, there are many
examples where phasing off the metal center alone was not sufficient
to solve the phase problem and other methods were needed. For example,
the structure of benzylsuccinate synthase, which has two intact [4Fe–4S]
clusters per heterohexamer (228 kDa), could not be solved using iron
anomalous data, and Se-SAD was instead used to determine phase information.[53] To determine the structure of the bifunctional
CODH/acetyl-CoA synthase (310 kDa), MAD phasing from the native clusters
was combined with molecular replacement phases, subject to multicrystal
averaging and 4-fold noncrystallographic symmetry averaging.[54]
Figure 5
Bound metallocofactor AdoCbl is exploited for phase information
in CarH. The crystal structure of two domains of the AdoCbl-dependent
transcription factor, CarH, was solved using anomalous scattering
of the cobalt ion.[52] (A) Experimental electron
density maps contoured at 1.2σ (purple) and anomalous electron
density map contoured at 5.0σ (yellow). (B) Ribbon trace of
AdoCbl, the Cbl-binding and helix bundle domains built into the electron
density. (C) Resulting structure of the C-terminal light sensing domains
of CarH.[52]
Bound metallocofactor AdoCbl is exploited for phase information
in CarH. The crystal structure of two domains of the AdoCbl-dependent
transcription factor, CarH, was solved using anomalous scattering
of the cobalt ion.[52] (A) Experimental electron
density maps contoured at 1.2σ (purple) and anomalous electron
density map contoured at 5.0σ (yellow). (B) Ribbon trace of
AdoCbl, the Cbl-binding and helix bundle domains built into the electron
density. (C) Resulting structure of the C-terminal light sensing domains
of CarH.[52]
Identification of Metals Present
There are a number
of different ways to identify which metal ions are present in a crystal,
including dispersive difference maps (shown in Figure B for SyrB2) and EDX. Recently, EDX was used
on calprotectin (CP), an immune response protein that coordinates
transition metal ions in a calcium-dependent manner. CP chelates and
sequesters metals, functionally depleting the supply of these metals
for use by pathogens.[55,56] In a recently determined structure
of Mn(II)Ca(II)CP, anomalous maps showed density consistent with Mn2+ in the Mn2+-binding site, but Ca2+ in only one of the two proposed Ca2+-binding sites, raising
questions of how many Ca2+-binding sites are really there
(Figure A).[57] EDX experiments were also performed on single
crystals of CP bound to a variety of metals, illustrating the use
of EDX to verify the presence and identity of metals within a single
crystal (Figure B).
Figure 6
A number
of techniques can be used to identify metals within metalloprotein
crystals. (A) Anomalous maps (1.54178 Å) contoured at 2.0σ
are consistent with Mn2+ in the Mn2+ site and
Ca2+ in only one of the two expected calcium-binding sites
shown in CP.[57] (B) EDX spectrum of a Mn(II)Ca(II)-bound CP indicates presence
of both metals (* indicates presence of K+). Panel A was
reprinted from ref (57).
A number
of techniques can be used to identify metals within metalloprotein
crystals. (A) Anomalous maps (1.54178 Å) contoured at 2.0σ
are consistent with Mn2+ in the Mn2+ site and
Ca2+ in only one of the two expected calcium-binding sites
shown in CP.[57] (B) EDX spectrum of a Mn(II)Ca(II)-bound CP indicates presence
of both metals (* indicates presence of K+). Panel A was
reprinted from ref (57).
Clarification of Proposed
Reaction Mechanisms
Copper-containing
nitrite reductases (CuNiRs) catalyze formation of nitric oxide from
reduction of nitrite, an important step in denitrification.[18] CuNiRs contain two copper centers (Cu-center):
a type I copper site involved in electron transfer and a type II copper
site for binding nitrite. A combination of X-ray crystallography and
spectroscopic experiments on CuNiR from Alcaligenes xylosoxidans (AxNiR) provided support for an ordered mechanism for electron transfer
in CuNiRs. UV–vis spectroscopy on the CuNiR blue crystal indicated
that the type I Cu center is in the Cu2+ oxidation state
prior to X-ray exposure but becomes reduced after data collection
(Figure ).[18] EXAFS was used to investigate the oxidation
state of the type II Cu center, revealing that, in the absence of
nitrite, this site remains oxidized.[18] These
results give strong evidence for the proposed ordered mechanism, in
which the type I Cu center transfers an electron to the type II Cu
center to catalyze the reaction, when the substrate is bound.[18]
Figure 7
Parallel UV–vis spectroscopy and X-ray crystallography
lend
support to an ordered mechanism proposed for AxNiR. The intense peak
at 595 nm is characteristic of a type I Cu2+ site and disappears
after exposure to X-rays, consistent with reduction.[18] Reproduced with permission from ref (18). Copyright 2008 Elsevier
Ltd.
Parallel UV–vis spectroscopy and X-ray crystallography
lend
support to an ordered mechanism proposed for AxNiR. The intense peak
at 595 nm is characteristic of a type I Cu2+ site and disappears
after exposure to X-rays, consistent with reduction.[18] Reproduced with permission from ref (18). Copyright 2008 Elsevier
Ltd.
Determination of Crystallized
Protein Activity
A fundamental
challenge in the interpretation of protein crystallographic data is
unawareness about whether the structure represents an active or inactive
state of the enzyme. For crystals with optically active metals, microspectrophotometry
allows assessment of whether the exact structure observed crystallographically
is catalytically active. In a study of CFeSP/methyl transferase (MeTr)
complex from M. thermoacetica, microspectrophotometry
was used to show that crystals of the metalloprotein complex were
active (Figure ),
an incredible result given that the structure revealed the need for
a 17 Å movement of the Cbl-binding domain of CFeSP to get close
enough to the methyltetrahydrofolate-binding site on the MeTr for
methyl transfer.[15] This long distance could
have meant that the structure was of an inactive state, but instead
these spectroscopic data showed in crystallo methylation,
indicating that the conformation of the enzyme observed in the crystal
structure was “on pathway”.[15]
Figure 8
UV–vis
of the CFeSP/MeTr crystals show that crystalline
protein is active.[15] The spectrum of the
CFeSP/MeTr (as-isolated) crystal has features at ∼400 and 470
nm, corresponding to the [4Fe–4S] cluster and Cbl cofactor.[15] Reducing the crystal with Ti(III)-citrate yields
a sharp peak at 390 nm, consistent with active Co(I)–Cbl.[15] Addition of CH3–H4folate results in a decrease at 390 nm and a new peak at 450 nm,
characteristic of product complex for protein-bound CH3–Co(III).[15] Figure is reprinted
from ref (15).
UV–vis
of the CFeSP/MeTr crystals show that crystalline
protein is active.[15] The spectrum of the
CFeSP/MeTr (as-isolated) crystal has features at ∼400 and 470
nm, corresponding to the [4Fe–4S] cluster and Cbl cofactor.[15] Reducing the crystal with Ti(III)-citrate yields
a sharp peak at 390 nm, consistent with active Co(I)–Cbl.[15] Addition of CH3–H4folate results in a decrease at 390 nm and a new peak at 450 nm,
characteristic of product complex for protein-bound CH3–Co(III).[15] Figure is reprinted
from ref (15).
Summary
The prevalence
of metals and metallocofactors in proteins speaks
to the importance of understanding how they are used in biochemical
reactions. Recent advances implemented at synchrotron facilities,
including incorporation of spectroscopic equipment and detectors that
allow simultaneous experiments on single crystals, provides a wealth
of new information that can be coupled with the crystallographic structures,
revealing details that may otherwise be impossible or difficult to
resolve. Although these methods are outside of the scope of this Account,
further exciting developments include X-ray free electron laser (XFEL)
sources, which produce very short, bright X-ray pulses that effectively
outrun radiation damage and oxidation state changes.
Authors: Oliver Einsle; F Akif Tezcan; Susana L A Andrade; Benedikt Schmid; Mika Yoshida; James B Howard; Douglas C Rees Journal: Science Date: 2002-09-06 Impact factor: 47.728
Authors: J T Jarrett; M Amaratunga; C L Drennan; J D Scholten; R H Sands; M L Ludwig; R G Matthews Journal: Biochemistry Date: 1996-02-20 Impact factor: 3.162
Authors: Derek M Gagnon; Megan Brunjes Brophy; Sarah E J Bowman; Troy A Stich; Catherine L Drennan; R David Britt; Elizabeth M Nolan Journal: J Am Chem Soc Date: 2015-02-18 Impact factor: 15.419
Authors: Jessica L Vey; Jian Yang; Meng Li; William E Broderick; Joan B Broderick; Catherine L Drennan Journal: Proc Natl Acad Sci U S A Date: 2008-10-13 Impact factor: 11.205
Authors: Andrew M Sydor; Marco Jost; Katherine S Ryan; Kaitlyn E Turo; Colin D Douglas; Catherine L Drennan; Deborah B Zamble Journal: Biochemistry Date: 2013-03-12 Impact factor: 3.162
Authors: Katarzyna B Handing; Ewa Niedzialkowska; Ivan G Shabalin; Misty L Kuhn; Heping Zheng; Wladek Minor Journal: Nat Protoc Date: 2018-04-19 Impact factor: 13.491
Authors: Helena Taberman; Charles S Bury; Mark J van der Woerd; Edward H Snell; Elspeth F Garman Journal: J Synchrotron Radiat Date: 2019-06-24 Impact factor: 2.616
Authors: Toshiki G Nakashige; Sarah E J Bowman; Emily M Zygiel; Catherine L Drennan; Elizabeth M Nolan Journal: Biochemistry Date: 2018-06-26 Impact factor: 3.162